Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma

被引：0
|
作者：
Mantovani, G. [1 ]
机构：
[1] Univ Cagliari, Dept Med Oncol, I-09124 Cagliari, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷 / 07期
关键词：
D O I：
10.1093/annonc/mdn290
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1355 / 1355
页数：1
相关论文
共 50 条
  • [31] Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus
    S. Kado
    T. Nagase
    N. Nagata
    Acta Diabetologica, 1999, 36 : 67 - 72
  • [32] Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus
    Kado, S
    Nagase, T
    Nagata, N
    ACTA DIABETOLOGICA, 1999, 36 (1-2) : 67 - 72
  • [33] Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma
    Chau, GY
    Wu, CW
    Lui, WY
    Chang, TJ
    Kao, HL
    Wu, LH
    King, KL
    Loong, CC
    Hsia, CY
    Chi, CW
    ANNALS OF SURGERY, 2000, 231 (04) : 552 - 558
  • [34] INDUCTION OF INTERFERON-BETA-2 INTERLEUKIN-6 (IL-6) BY CYTOKINE ADMINISTRATION AND DETECTION OF CIRCULATING INTERLEUKIN-6 IN THE TUMOR-BEARING STATE
    JABLONS, DM
    MCINTOSH, JK
    MULE, JJ
    NORDAN, RP
    RUDIKOFF, S
    LOTZE, MT
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1989, 557 : 157 - 161
  • [35] INDUCTION OF INTERFERON-BETA-2 INTERLEUKIN-6 (IL-6) BY CYTOKINE ADMINISTRATION AND DETECTION OF CIRCULATING INTERLEUKIN-6 IN THE TUMOR-BEARING STATE
    JABLONS, DM
    MCINTOSH, JK
    MULE, JJ
    NORDAN, RP
    RUDIKOFF, S
    LOTZE, MT
    REGULATION OF THE ACUTE PHASE AND IMMUNE RESPONSES : INTERLEUKIN-6, 1989, 557 : 157 - 161
  • [36] Circulating Tumor DNA and Hepatocellular Carcinoma
    Yang, Ju Dong
    Liu, Minetta C.
    Kisiel, John B.
    SEMINARS IN LIVER DISEASE, 2019, 39 (04) : 452 - 462
  • [37] Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
    Amal Gad
    Eiji Tanaka
    Akihiro Matsumoto
    Moushira Abd-el Wahab
    Abd el-Hamid Serwah
    Fawzy Attia
    Khalil Ali
    Howayda Hassouba
    Abd el-Raoof el-Deeb
    Tetsuya Ichijyo
    Takeji Umemura
    Hidetomo Muto
    Kaname Yoshizawa
    Kendo Kiyosawa
    World Journal of Gastroenterology, 2005, (42) : 6607 - 6612
  • [38] Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
    Gad, Amal
    Tanaka, Eiji
    Matsumoto, Akihiro
    Abd-el Wahab, Moushira
    Serwah, Abd El-Hamid
    Attia, Fawzy
    Ali, Khalil
    Hassouba, Howayda
    el-Deeb, Abd el-Raoof
    Ichijyo, Tetsuya
    Umemura, Takeji
    Muto, Hidetomo
    Yoshizawa, Kaname
    Kiyosawa, Kendo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (42) : 6607 - 6612
  • [39] Detection of Serum Kl-6 as a Tumor Marker in Hepatocellular Carcinoma
    El-Shenawy, Soha Z.
    El-Sabawy, Maha M.
    Abd El-Razik, Eman
    Allam, Maha M.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (01): : 667 - 673
  • [40] Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Wu, Yanqin
    Fan, Wenzhe
    Xue, Miao
    Zhong, Bihui
    Zhang, Shenghong
    Wang, Yu
    Yao, Wang
    Zhao, Yue
    Li, Jiaping
    ONCOLOGIST, 2019, 24 (12): : E1489 - E1495
12345